Gut microbiome in down syndrome

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Biagi, Elena ^a   Cela, Marco ^a   Centanni, Manuela ^a   Consoli, Clarissa ^b   Rampelli, Simone ^a   Turroni, Silvia ^a   Severgnini, Marco ^b   Peano, Clelia ^b   Ghezzo, Alessro ^a   Scurti, Maria ^a   Salvioli, Stefano ^a   Franceschi, Claudio ^a   Brigidi, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

16S RRNA GENE; ABERRANT BEHAVIOR CHECKLIST TOTAL SCORE; ADAPTIVE BEHAVIOR; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL STRUCTURES; BACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOWN SYNDROME; DSM-IV; FEMALE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; MALE; NEUROPSYCHIATRY; NONHUMAN; OBSERVATIONAL STUDY; PARASPOROBACTERIUM; PATHOGENESIS; PHYLOGENY; POPULATION ABUNDANCE; PROMOTER REGION; PYROSEQUENCING; RATING SCALE; SCORING SYSTEM; SENESCENCE; SUTTERELLA; TRISOMY; VINELAND ADAPTIVE BEHAVIOR SCALE; WECHSLER SCALE; AGING; FECES; GENETICS; MICROBIOLOGY; YOUNG ADULT;

ADULT; AGING; DOWN SYNDROME; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 84911423118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112023     Document Type: Article

References (44)

1. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, et al; National Birth Defects Prevention Network (2010) Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88(12): 1008-1116.
2. Zigman WB (2013) Atypical aging in Down syndrome. Dev Disabil Res Rev 18(1): 51-67.
3. Nakamura E, Tanaka S (1998) Biological ages of adult men and women with Down's syndrome and its changes with aging. Mech Ageing Dev 105(1-2): 89-103.
4. Bittles AH, Glasson EJ (2004) Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 46(4): 282-286.
5. Patterson D, Cabelof DC (2012) Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging. Mech Ageing Dev 133(4): 133-137.
6. Trotta MB, Serro Azul JB, Wajngarten M, Fonseca SG, Goldberg AC, et al. (2011) Inflammatory and Immunological parameters in adults with Down syndrome. Immun Ageing 8(1): 4.
7. Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M, et al. (1990) Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl 7: 213-218.
8. Cossarizza A, Ortolani C, Forti E, Montagnani G, Paganelli R, et al. (1991) Agerelated expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 77(6): 1263-1270.
9. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, et al. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86(19): 7611-7615.
10. Broers CJ, Gemke RJ, Weijerman ME, van der Sluijs KF, van Furth AM (2012) Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus. J Clin Immunol 32(2): 323-329.
11. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, et al. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244-254.
12. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128(1): 92-105.
13. Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci (Suppl 1): S4-S9.
14. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, et al. (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5(5): e10667.
15. Biagi E, Candela M, Franceschi C, Brigidi P (2011) The aging gut microbiota: new perspectives. Ageing Res Rev 10(4): 428-429.
16. Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, et al. (2013) Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res 69(1): 11-20.
17. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500(7461): 232-236.
18. Kamada N, Chen GY, Inohara N, Nu?n?ez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14(7): 685-690.
19. Roizen NJ, Patterson D (2003) Down's syndrome. Lancet 361(9365): 1281-1289.
20. Aman MG, Singh NN, Stewart AW, Field CJ (1985) The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 89: 485-491.
21. Ji NY, Capone GT, Kaufmann WE (2011) Autism spectrum disorder in Down syndrome: cluster analysis of Aberrant Behaviour Checklist data supports diagnosis. J Intellect Disabil Res 55(11): 1064-1077.
22. Williams BL, Hornig M, Parekh T, Lipkin WI (2012) Application of novel PCRbased methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio 3(1). pii: e00261-11.
23. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, et al. (2013) Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism 4(1): 42.
24. Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, et al. (2014) Gut microbiome of the Hadza hunter-gatherers. Nat Commun 5: 3654.
25. Rampelli S, Candela M, Turroni S, Biagi E, Collino S, et al. (2013) Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging (Albany NY) 5: 902-912.
26. Sparrow SS, Balla DA, Cicchetti DV (1984) Vineland adaptive behavior scales. Circles Pines, MN: American Guidance Service.
27. Balboni G, Pedrabissi L (2003) Adattamento italiano delle Vineland Adaptive Behavior Scales. Firenze: O.S. Organizzazioni Speciali.
28. Salonen A, Nikkila? J, Jalanka-Tuovinen J, Immonen O, Rajilic? -Stojanovic? M, et al. (2010) Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 81(2): 127-134.
29. Claesson MJ, O'Sullivan O, Wang Q, Nikkila J, Marchesi JR, et al. (2009) Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One 4(8): e6669.
30. Culhane AC, Thioulouse J, Perriere G, Higgins DG (2005) MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics 21: 2789-2790.
31. Physical Status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. (1995) World Health Organ Tech Rep Ser 854: 1-452.
32. Lozupone CA, Stombaugh J, Gonzalez A, Ackermann G, Wendel D, et al. (2013) Meta-analyses of studies of the human microbiota. Genome Res 23(10): 1704-1714.
33. Benach JL, Li E, McGovern MM (2012) A microbial association with autism. MBio 14: 3(1).
34. Biagi E, Candela M, Fairweather-Tait S, Franceschi C, Brigidi P (2012) Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 34(1): 247-267.
35. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA (2008) Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6(2): 121-131.
36. Fischbach MA, Sonnenburg JL (2011) Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 10(4): 336-347.
37. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469(7331): 543-547.
38. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, et al. (2012) Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 109(6): 2108-2113.
39. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory Tcell generation. Nature 504(7480): 451-455.
40. Li C, Jin L, Bai Y, Chen Q, Fu L, et al. (2012) Genome-wide expression analysis in Down syndrome: insight into immunodeficiency. PLoS One 7(11): e49130.
41. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484): 559-563.
42. Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, et al. (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8(7): e68322.
43. Carter JC, Capone GT, Gray RM, Cox CS, Kaufmann WE (2007) Autisticspectrum disorders in Down syndrome: further delineation and distinction from other behavioral abnormalities. Am J Med Genet B Neuropsychiatr Genet 144B (1): 87-94.
44. Adams JB, Romdalvik J, Levine KE, Hu LW (2008) Mercury in first-cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 90: 739-753.